Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$34.2 - $47.13 $2.19 Million - $3.01 Million
-63,933 Reduced 49.08%
66,332 $2.91 Million
Q4 2023

Feb 14, 2024

SELL
$24.59 - $35.83 $59,901 - $87,281
-2,436 Reduced 1.84%
130,265 $4.63 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $112,977 - $159,626
5,362 Added 4.21%
132,701 $3.58 Million
Q2 2023

Aug 11, 2023

BUY
$13.33 - $25.53 $1.7 Million - $3.25 Million
127,339 New
127,339 $2.99 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $998M
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.